Build the way
biology becomes material.
Avenyx is working toward a manufacturing platform for native biomaterials, beginning with Type I collagen and a global customer opportunity.
Parth Shinde.
Founder & CEO · BITS Pilani
Leading the business and technical development of Avenyx, from laboratory work toward a reproducible manufacturing system.
Meet through a conversation ↗Precision.
Repeatability.
Dependable quality.
Global ambition.
A deliberate foundation.
We’re exploring a patent filing and company registration in Japan. Both remain plans under consideration.
Our customer opportunity spans the international field of regenerative research and development. The work ahead is to turn a lab-validated process into dependable supply.
Five organizations.
Shared exploration.
Organizations developing applications with Avenyx materials, as reported in our company deck.



People behind
the progress.


Logos identify advisor affiliations; they do not imply institutional endorsement.
